Radius Health, Inc., a biopharmaceutical company, develops and commercializes endocrine and other therapeutics. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a short-wear-time transdermal patch that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical trials for the treatment of hormone receptor-positive breast cancer; and RAD011, which is in Phase II clinical trials for treatment of hyperphagia related to Prader-Willi syndrome. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Teijin Limited; Berlin-Chemie AG; Eisai Co. Ltd.; and Duke University. Radius Health, Inc. was founded in 2003 and is headquartered in Boston, Massachusetts.
IPO Year:
Exchange: NASDAQ
Website: radiuspharm.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/2/2024 | $22.00 | Neutral | Goldman |
| 5/30/2024 | Sell → Neutral | Seaport Research Partners | |
| 2/28/2024 | $17.50 | Neutral → Sell | Seaport Research Partners |
| 12/14/2023 | Neutral | Seaport Research Partners | |
| 6/8/2022 | $8.00 | Underperform → Neutral | BofA Securities |
| 5/23/2022 | $7.00 | Mkt Perform | SVB Leerink |
| 12/10/2021 | $18.00 → $7.00 | Equal-Weight → Underweight | Morgan Stanley |
| 12/10/2021 | $33.00 → $12.00 | Buy → Neutral | Goldman Sachs |
| 12/9/2021 | $30.00 → $20.00 | Market Perform | SVB Leerink |
| 12/9/2021 | $23.00 → $10.00 | Neutral | HC Wainwright & Co. |
PORTLAND, Ore., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) today reported results for the first quarter of fiscal 2025 ended November 30, 2024. The Company reported a loss per share from continuing operations of $(1.30) and a net loss of $(37) million in the first quarter of fiscal 2025, compared to ($0.64) and ($18) million, respectively, in the prior year first quarter, with the difference substantially driven by a detriment on income tax in the current quarter. Adjusted EBITDA was break-even in the first quarter of fiscal 2025, compared to $1 million in the prior year first quarter. Adjusted loss per share from continuing operations was $(1.33) in the firs
BOSTON, MA / ACCESSWIRE / January 2, 2025 / Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc. ("Radius" or the "Company"), a specialty biopharmaceutical company focused on bone health and related areas, announced today it has granted Pharmanovia the exclusive commercialization rights to abaloparatide, a novel bone forming agent indicated for the treatment of osteoporosis in postmenopausal women and men at increased risk of fractures. The licensing agreement covers markets in the Asia Pacific region, specifically China, Singapore, Thailand, Indonesia, Vietnam, Taiwan, Hong Kong, Malaysia, Macau and the Philippines. Abaloparatide is marketed in the U.S. by Radius u
PORTLAND, Ore., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) announced that the Company will report financial results for its first quarter fiscal 2025 ended November 30, 2024 on Wednesday, January 8, 2025. The Company will host a webcast conference call to discuss the results at 11:30 a.m. Eastern Time on the same day. The webcast of the call and the accompanying slide presentation may be accessed on Radius Recycling's website at www.radiusrecycling.com/company/investors. The call will be hosted by Tamara Lundgren, Chairman and Chief Executive Officer, and Stefano Gaggini, Senior Vice President and Chief Financial Officer. About Radius Recycling, Inc. Radius Re
PORTLAND, Ore., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Radius Recycling (NASDAQ:RDUS), a global leader in metals recycling, today announced the release of the Company's Fiscal 2024 Sustainability Report. The report highlights the Company's role in the transition to a low-carbon future by supplying recycled metals that are critical to the production of more sustainable products, including those associated with global decarbonization efforts. "Nearly 10 years ago, we created a sustainability framework based on three pillars: People, Planet, and Profit," said Tamara Lundgren, Chairman and Chief Executive Officer. "This framework is the foundation of our sustainability strategy and continues to
BOSTON, MA / ACCESSWIRE / December 9, 2024 / Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc. ("Radius" or the "Company"), a specialty biopharmaceutical company focused on bone health and related areas, announced today it has granted Theramex the exclusive commercialization rights to ELADYNOS® (abaloparatide), a novel bone forming agent indicated for the treatment of osteoporosis in postmenopausal women and men at increased risk of fractures, for Mexico, Canada, Israel, South Africa, and Russia. Theramex will also have the opportunity to commercialize ELADYNOS® in other agreed upon unpartnered regions. Abaloparatide is marketed in the U.S. by Radius under the tr
PORTLAND, Ore., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) today announced the appointment of Marc Hathhorn as Executive Vice President and Chief Operating Officer, effective November 1, 2024. Hathhorn joins Radius from Peabody Energy Corporation (NYSE:BTU) and brings more than 30 years of leadership experience in the mining industry. Most recently, Hathhorn held the position of President--Global Operations at Peabody Energy Corporation (NYSE:BTU), overseeing 5,000 employees and 17 coal mines across the U.S. and Australia. Under Hathhorn's leadership, Peabody achieved multiple safety performance awards, exceeded environmental management and compliance goals, an
PORTLAND, Ore., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) announced that its Board of Directors has appointed Mauro Gregorio, the recently retired President of the Performance Materials & Coatings Division at Dow Inc. (NYSE:DOW), as a new independent director, effective November 1, 2024. Mr. Gregorio will serve on the Audit Committee and the Compensation and Human Resources Committee of the Board. Over his nearly 40-year career at Dow, Mr. Gregorio served in multiple roles, including leading the post-acquisition integration of Dow Corning, overseeing the company's feedstock and energy business unit, and serving as global Vice President for the Hygiene and Medi
Significant Sequential Improvement in Operating and Financial Performance in Q4 Ferrous, Nonferrous and Finished Steel Sales Volumes Up Sequentially Radius Board Declares Quarterly Dividend PORTLAND, Ore., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) today reported results for the fourth quarter and fiscal year ended August 31, 2024. The Company reported a net loss of $(16) million, or $(13) per ferrous ton, and a loss per share from continuing operations in the fourth quarter of fiscal 2024 of $(0.56), a significant improvement compared to the third quarter which included a material goodwill impairment charge. Adjusted EBITDA in the fourth quarter was $17 mi
PORTLAND, Ore., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) announced that the Company will report financial results for its fourth quarter and fiscal 2024 ended August 31, 2024 on Thursday, October 24, 2024. The Company will host a webcast conference call to discuss the results at 11:30 a.m. Eastern Time on the same day. The webcast of the call and the accompanying slide presentation may be accessed on Radius Recycling's website at www.radiusrecycling.com/company/investors. The call will be hosted by Tamara Lundgren, Chairman and Chief Executive Officer, and Stefano Gaggini, Senior Vice President and Chief Financial Officer. About Radius Recycling, Inc. Radiu
Ferrous, Nonferrous and Finished Steel Sales Volumes Up Sequentially Radius Board Declares Quarterly Dividend PORTLAND, Ore., July 02, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) today reported results for the third quarter of fiscal 2024 ended May 31, 2024. The Company's reported and adjusted results differed significantly this quarter. Due primarily to a non-cash goodwill impairment charge reflecting the challenging market conditions for recycled metals experienced during the last year, the Company reported a loss per share from continuing operations of $(6.97) and a net loss of $(199) million in the third quarter. These results included
4 - RADIUS RECYCLING, INC. (0000912603) (Issuer)
4 - RADIUS RECYCLING, INC. (0000912603) (Issuer)
4 - RADIUS RECYCLING, INC. (0000912603) (Issuer)
4 - RADIUS RECYCLING, INC. (0000912603) (Issuer)
4 - RADIUS RECYCLING, INC. (0000912603) (Issuer)
4 - RADIUS RECYCLING, INC. (0000912603) (Issuer)
4 - RADIUS RECYCLING, INC. (0000912603) (Issuer)
4 - RADIUS RECYCLING, INC. (0000912603) (Issuer)
4 - RADIUS RECYCLING, INC. (0000912603) (Issuer)
4 - RADIUS RECYCLING, INC. (0000912603) (Issuer)
PORTLAND, Ore., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) today reported results for the first quarter of fiscal 2025 ended November 30, 2024. The Company reported a loss per share from continuing operations of $(1.30) and a net loss of $(37) million in the first quarter of fiscal 2025, compared to ($0.64) and ($18) million, respectively, in the prior year first quarter, with the difference substantially driven by a detriment on income tax in the current quarter. Adjusted EBITDA was break-even in the first quarter of fiscal 2025, compared to $1 million in the prior year first quarter. Adjusted loss per share from continuing operations was $(1.33) in the firs
PORTLAND, Ore., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) announced that the Company will report financial results for its first quarter fiscal 2025 ended November 30, 2024 on Wednesday, January 8, 2025. The Company will host a webcast conference call to discuss the results at 11:30 a.m. Eastern Time on the same day. The webcast of the call and the accompanying slide presentation may be accessed on Radius Recycling's website at www.radiusrecycling.com/company/investors. The call will be hosted by Tamara Lundgren, Chairman and Chief Executive Officer, and Stefano Gaggini, Senior Vice President and Chief Financial Officer. About Radius Recycling, Inc. Radius Re
Significant Sequential Improvement in Operating and Financial Performance in Q4 Ferrous, Nonferrous and Finished Steel Sales Volumes Up Sequentially Radius Board Declares Quarterly Dividend PORTLAND, Ore., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) today reported results for the fourth quarter and fiscal year ended August 31, 2024. The Company reported a net loss of $(16) million, or $(13) per ferrous ton, and a loss per share from continuing operations in the fourth quarter of fiscal 2024 of $(0.56), a significant improvement compared to the third quarter which included a material goodwill impairment charge. Adjusted EBITDA in the fourth quarter was $17 mi
PORTLAND, Ore., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) announced that the Company will report financial results for its fourth quarter and fiscal 2024 ended August 31, 2024 on Thursday, October 24, 2024. The Company will host a webcast conference call to discuss the results at 11:30 a.m. Eastern Time on the same day. The webcast of the call and the accompanying slide presentation may be accessed on Radius Recycling's website at www.radiusrecycling.com/company/investors. The call will be hosted by Tamara Lundgren, Chairman and Chief Executive Officer, and Stefano Gaggini, Senior Vice President and Chief Financial Officer. About Radius Recycling, Inc. Radiu
Ferrous, Nonferrous and Finished Steel Sales Volumes Up Sequentially Radius Board Declares Quarterly Dividend PORTLAND, Ore., July 02, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) today reported results for the third quarter of fiscal 2024 ended May 31, 2024. The Company's reported and adjusted results differed significantly this quarter. Due primarily to a non-cash goodwill impairment charge reflecting the challenging market conditions for recycled metals experienced during the last year, the Company reported a loss per share from continuing operations of $(6.97) and a net loss of $(199) million in the third quarter. These results included
PORTLAND, Ore., June 18, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) announced that the Company will report financial results for its third quarter fiscal 2024 ended May 31, 2024 on Tuesday, July 2, 2024. The Company will host a webcast conference call to discuss the results at 11:30 a.m. Eastern Time on the same day. The webcast of the call and the accompanying slide presentation may be accessed on Radius Recycling's website at www.radiusrecycling.com/company/investors. The call will be hosted by Tamara Lundgren, Chairman and Chief Executive Officer, and Stefano Gaggini, Senior Vice President and Chief Financial Officer. About Radius Recycling, Inc. Radius Recycling, I
Nonferrous and Finished Steel Sales Volumes Up Year-Over-Year Increased Cost Reduction Target by $40 Million Radius Board Declares Quarterly Dividend PORTLAND, Ore., April 04, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) today reported results for the second quarter of fiscal 2024 ended February 29, 2024. The Company reported a loss per share from continuing operations of $(1.19) and a net loss of $(34) million. Adjusted EBITDA was $3 million and adjusted loss per share from continuing operations was $(1.04). Market conditions during the second quarter remained challenging, as tight supply flows for recycled metals and unusually wet winter weathe
Nonferrous and Finished Steel Sales Volumes Up Year-over-Year Cost Reduction Target Increased PORTLAND, Ore., March 14, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) today announced preliminary results for its fiscal 2024 second quarter ended February 29, 2024. Second Quarter Fiscal 2024 Expected Performance The Company anticipates: Net loss to be approximately $(35) million. Loss per share from continuing operations to be in the range of $(1.19) - $(1.24).Adjusted EBITDA to be approximately $2 million, and adjusted loss per share from continuing operations to be in the range of $(1.05) - $(1.10). Market Conditions, Prices, and Volumes. Tight supply flows for recycled
Ferrous, Nonferrous and Finished Steel Sales Volumes Up Year-Over-Year Radius Board Declares Quarterly Dividend Schnitzer Steel Industries, Inc. dba Radius Recycling (NASDAQ:RDUS) today reported results for the first quarter of fiscal 2024 ended November 30, 2023. The Company reported a loss per share from continuing operations of $(0.64) and a net loss of $(18) million. Adjusted loss per share from continuing operations was $(0.64) and adjusted EBITDA was $1 million. Operating performance in the first quarter reflected sequentially tighter supply flows for recycled metals, which, together with lower average net selling prices for the Company's products, resulted in a compression of
Schnitzer Steel Industries, Inc. dba Radius Recycling (NASDAQ:RDUS) announced that the Company will report financial results for its first quarter fiscal 2024 ended November 30, 2023 on Thursday, January 4, 2024. The Company will host a webcast conference call to discuss the results at 11:30 a.m. Eastern Time on the same day. The webcast of the call and the accompanying slide presentation may be accessed on Radius Recycling's website at www.radiusrecycling.com/company/investors. The call will be hosted by Tamara Lundgren, Chairman and Chief Executive Officer, and Stefano Gaggini, Senior Vice President and Chief Financial Officer. About Schnitzer Steel Industries, Inc. dba Radius Recycling
10-Q - RADIUS RECYCLING, INC. (0000912603) (Filer)
8-K - RADIUS RECYCLING, INC. (0000912603) (Filer)
DEFA14A - RADIUS RECYCLING, INC. (0000912603) (Filer)
DEF 14A - RADIUS RECYCLING, INC. (0000912603) (Filer)
8-K - RADIUS RECYCLING, INC. (0000912603) (Filer)
8-K - RADIUS RECYCLING, INC. (0000912603) (Filer)
8-K - RADIUS RECYCLING, INC. (0000912603) (Filer)
10-K - RADIUS RECYCLING, INC. (0000912603) (Filer)
8-K - RADIUS RECYCLING, INC. (0000912603) (Filer)
10-Q - RADIUS RECYCLING, INC. (0000912603) (Filer)
Submission status for RADIUS HEALTH INC's drug TYMLOS (SUPPL-13) with active ingredient ABALOPARATIDE has changed to 'Approval' on 12/19/2022. Application Category: NDA, Application Number: 208743, Application Classification: Efficacy
Submission status for RADIUS HEALTH INC's drug TYMLOS (SUPPL-10) with active ingredient ABALOPARATIDE has changed to 'Approval' on 12/22/2021. Application Category: NDA, Application Number: 208743, Application Classification: Efficacy
Submission status for RADIUS HEALTH INC's drug TYMLOS (SUPPL-10) with active ingredient ABALOPARATIDE has changed to 'Tentative Approval' on 10/28/2021. Application Category: NDA, Application Number: 208743, Application Classification: Efficacy
Submission status for RADIUS HEALTH INC's drug TYMLOS (SUPPL-9) with active ingredient ABALOPARATIDE has changed to 'Approval' on 09/20/2021. Application Category: NDA, Application Number: 208743, Application Classification: Efficacy
Goldman initiated coverage of Radius Recycling with a rating of Neutral and set a new price target of $22.00
Seaport Research Partners upgraded Radius Recycling from Sell to Neutral
Seaport Research Partners downgraded Radius Recycling from Neutral to Sell and set a new price target of $17.50
Seaport Research Partners initiated coverage of Radius Recycling with a rating of Neutral
BofA Securities upgraded Radius Health from Underperform to Neutral and set a new price target of $8.00
SVB Leerink initiated coverage of Radius Health with a rating of Mkt Perform and set a new price target of $7.00
Morgan Stanley downgraded Radius Health from Equal-Weight to Underweight and set a new price target of $7.00 from $18.00 previously
Goldman Sachs downgraded Radius Health from Buy to Neutral and set a new price target of $12.00 from $33.00 previously
SVB Leerink reiterated coverage of Radius Health with a rating of Market Perform and set a new price target of $20.00 from $30.00 previously
HC Wainwright & Co. reiterated coverage of Radius Health with a rating of Neutral and set a new price target of $10.00 from $23.00 previously
PORTLAND, Ore., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) today announced the appointment of Marc Hathhorn as Executive Vice President and Chief Operating Officer, effective November 1, 2024. Hathhorn joins Radius from Peabody Energy Corporation (NYSE:BTU) and brings more than 30 years of leadership experience in the mining industry. Most recently, Hathhorn held the position of President--Global Operations at Peabody Energy Corporation (NYSE:BTU), overseeing 5,000 employees and 17 coal mines across the U.S. and Australia. Under Hathhorn's leadership, Peabody achieved multiple safety performance awards, exceeded environmental management and compliance goals, an
PORTLAND, Ore., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) announced that its Board of Directors has appointed Mauro Gregorio, the recently retired President of the Performance Materials & Coatings Division at Dow Inc. (NYSE:DOW), as a new independent director, effective November 1, 2024. Mr. Gregorio will serve on the Audit Committee and the Compensation and Human Resources Committee of the Board. Over his nearly 40-year career at Dow, Mr. Gregorio served in multiple roles, including leading the post-acquisition integration of Dow Corning, overseeing the company's feedstock and energy business unit, and serving as global Vice President for the Hygiene and Medi
Urges Stockholders to Vote "FOR" Radius' Highly Qualified, Independent Director Nominees – Catherine J. Friedman, Jean-Pierre Garnier, Ph.D. and Andrew C. von Eschenbach, M.D. – on the BLUE Proxy Card Details Company's Significant Progress Since 2020, Under Refreshed Board and Management Team BOSTON, June 06, 2022 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius" or the "Company") (NASDAQ:RDUS) today announced that it has filed its definitive proxy statement with the Securities and Exchange Commission ("SEC") for its upcoming Annual Meeting of Stockholders, which will be held online on July 8, 2022. Stockholders of record as of June 3, 2022, will be entitled to vote at the meeting. In c
EMERYVILLE, Calif., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (NASDAQ:BLI), a leader in digital cell biology, today announced the appointment of Jessica Hopfield, Ph.D. to the Berkeley Lights' Board of Directors as an independent director, effective December 15, 2021. "Dr. Hopfield is a respected and accomplished industry veteran, and we are thrilled to welcome her to our Board," said Eric Hobbs, Ph.D., chief executive officer of Berkeley Lights. "With more than two decades of medical device, biotech and pharmaceutical experience, Dr. Hopfield brings to Berkeley Lights valuable strategic insight and a strong focus on performance to drive our unrivaled ability to understand c
CAMBRIDGE, United Kingdom--(BUSINESS WIRE)--Wren Therapeutics Ltd., (“Wren”), a biopharmaceutical company pioneering a unique network kinetics approach to drug discovery for protein misfolding diseases, today announced the closing of a £12.4 million (c. $17.0 million) financing. This financing brings the total capital raised to date to approximately £33 million (c. $45 million). The financing was led by existing shareholder The Baupost Group, with participation from existing investors including LifeForce Capital and new investors including Schooner Capital and Industry Ventures. Dr. Samuel Cohen, Chief Executive Officer of Wren, commented: “This support from both our existing as
BOSTON, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS) announced today that Machelle Sanders and Dr. Andrew C. von Eschenbach have joined the Company’s board of directors. Ms. Sanders and Dr. von Eschenbach will fill vacancies created by the departures of Jessica Hopfield, Ph.D. and Tony Rosenberg, who stepped down from the board on December 31, 2020 after years of service. Owen Hughes, Chairman of the Radius Board of Directors commented, “We are absolutely delighted to welcome both Machelle and Andy to the Radius board. Machelle’s extensive experience in complex supply chain management, manufacturing and quality assurance will prove inval
SC 13G/A - RADIUS RECYCLING, INC. (0000912603) (Subject)
SC 13G/A - RADIUS RECYCLING, INC. (0000912603) (Subject)
SC 13G/A - RADIUS RECYCLING, INC. (0000912603) (Subject)
SC 13G/A - RADIUS RECYCLING, INC. (0000912603) (Subject)
SC 13D/A - Radius Health, Inc. (0001428522) (Subject)
SC 13D/A - Radius Health, Inc. (0001428522) (Subject)
SC 13G - Radius Health, Inc. (0001428522) (Subject)
SC 13D/A - Radius Health, Inc. (0001428522) (Subject)
SC 13G/A - Radius Health, Inc. (0001428522) (Subject)
SC 13D - Radius Health, Inc. (0001428522) (Subject)